Sanofi abandons deal for rare disease drug

The latest stories trending on MedCity News.

Editor's Pick

Top Story Sanofi Abandons Deal for Rare Disease Drug Amid FTC's Monopoly Concerns Sanofi, which markets the two primary treatments for Pompe disease, was trying to add a third one by licensing rights to a Maze Therapeutics drug candidate with a different therapeutic approach. A Federal Trade Commission complaint alleges the deal amounts to a monopoly player taking out its competition. Only 3 Days Left To Save Extreme Early Bird Rate of $795 ends this Friday night. Hurry, this is your last chance to get the lowest rate on INVEST 2024. Don't miss out. Register Now

Featured News

Americans' Healthcare Costs Are Rising With the Pace of Inflation, Report Says During the first three quarters of 2023, the prices for CMS' 500 shoppable services increased by 2.0%, according to a new report. This figure is in alignment with the 1.9% U.S. inflation measured by the Personal Consumption Expenditures Price Index and below the overall U.S. inflation rate measured by the Consumer Price Index. AstraZeneca's Icosavax M&A Deal Helps It Stand Out in Multivalent Vaccines Chase AstraZeneca is acquiring Icosavax, which has technology well-suited for multivalent vaccines. Icosavax's pipeline includes a Phase 3-ready program that protects against two pathogens that cause severe respiratory infections in older adults. Bipartisan Price Transparency Bill Passes in House The Lower Costs, More Transparency Act has passed in the House with bipartisan support. The action is being applauded from several advocacy organizations. Talkspace, Evernow Partner To Advance Mental Health, Menopause Care Talkspace is offering free self-guided mental health content to some female Evernow customers over the age of 40, while Evernow is offering discounted menopause care to Talkspace patients. MedCity Pivot: How a Health Center Serving Low Income Patients Engaged Them In Their Own Health In the last episode of the year, Wrobel, CEO of an Indiana-based federally qualified health center, describes how a survey helped her and her community workers understand exactly how confident her patients are in managing their own care and the best way to help them with the ultimate goal of improving overall health equity. Navigating a Successful M&A Integration Process Integrations are incredibly destabilizing and stressful for impacted employees, as well as for those who "survive." Organizations that are worth acquiring are successful and attractive because they are comprised of smart, talented people who have created that success. AI Enhances Workflows; It Doesn't Replace Physicians. The integration of AI into cardiology workflows can help triage care automatically, ensuring the right physicians weigh in on patient data at the right time which may potentially improve clinical outcomes for all patients in need. How Organizations Can Lower Their Risks of Diversion While there will never be a perfect solution to preventing drug diversion 100% of the time, leveraging the right people, processes and technology is our best chance of keeping patients safe.

Resources

How To Enable Hyperpersonal Care Amid transitioning consumer expectations, an evolving care delivery model, and a significant workforce crisis, health systems need to change the way they do business and harness the right technology to create an effective solution. This webinar will feature expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients and barriers that hold health systems back. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe